Trials / Not Yet Recruiting
Not Yet RecruitingNCT07536048
A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years
A Multi-center, Prospective, Longitudinal Cohort Study to Collect Immunological and Clinical Data on Epstein-Barr Virus (EBV) Reactivation in EBV Seropositive Male and Female Adults Aged 18 to 29 Years
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Sanofi Pasteur, a Sanofi Company · Industry
- Sex
- All
- Age
- 18 Years – 29 Years
- Healthy volunteers
- Accepted
Summary
This multi-center, prospective, longitudinal cohort study is designed to gather immunological and clinical data on EBV reactivation in EBV seropositive adults aged 18 to 29 years. This study will follow a cohort of approximately 100 EBV seropositive adults 18 to 29 years of age in Australia over a 6 or 12-month period. Participants will not receive any study intervention (eg, study treatments, vaccines).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Investigational Procedure | It consists of prospective blood and saliva collections. Study without any IMP administration. |
Timeline
- Start date
- 2026-04-20
- Primary completion
- 2027-05-19
- Completion
- 2027-05-19
- First posted
- 2026-04-17
- Last updated
- 2026-04-17
Source: ClinicalTrials.gov record NCT07536048. Inclusion in this directory is not an endorsement.